Peri-implant Conditions Mimic Periodontal Conditions

Periodontitis Clinical Trial

Official title:

Peri-implant Health and Disease Mimic Periodontal Health and Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06128850
• Other study ID #: 2022/163
• Status: Completed
• Start date: July 4, 2022
• Est. completion date: March 31, 2023

Study information

• Verified date: November 2023
• Source: Abant Izzet Baysal University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Except for patients with referred clinical bruxism and uncontrolled medical conditions, the study included 123 implants with implanted fixed prostheses that had lasted at least six months after functional prosthetic loading. In all implant patients, the health scale ranged from implants and natural teeth to plaque, gingival index, bleeding in the probe, mouth depth, loss of clinical attachment, and dental implants. The health and illness of the implants have been determined. Patients were divided into three groups: peri-implantitis, peri-implant mucositis, and peri-implant health.

Inclusion Criteria:

• Patients between the ages of 18- 70

• Drugs that have a systemically healthy and controlled treatment situation

• Drivers who have implant-supported fixed prostheses that have been at least six months after functional prosthetic loading Among these groups, it was checked whether periodontitis was seen in patients with peri-implantitis, gingivitis in patients with peri-implant mucositis, and whether healthy gums were seen in individuals with peri-implant health.

To determine the health and disease status of individuals' implants, plaque index (Silness Loe 1964), gingival index (Loe Silness 1963), bleeding on probing (Ainoma Bay 1975), pocket depth measurements, and clinical attachment level were collected.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 143
• Est. completion date: March 31, 2023
• Est. primary completion date: July 4, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Patients between the ages of 18- 70

• Drugs that have a systemically healthy and controlled treatment situation

• Drivers who have implant-supported fixed prostheses that have been at least six months after functional prosthetic loading

Exclusion Criteria:

• Bruxism

• Uncontrolled medical conditions

Related Conditions & MeSH terms

• Gingivitis
• Mucositis
• Peri-implant Mucositis
• Peri-Implantitis
• Periodontitis

Intervention

Other:
• disease
compare to diseases

Locations

Country	Name	City	State
Turkey	Bolu Abant Izzet Baysal University	Bolu

Sponsors (1)

Lead Sponsor	Collaborator
Abant Izzet Baysal University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Plaque index	The plaque index assesses the amount of dental plaque visible on the vestibular and lingual surfaces of all teeth	Baseline
Primary	Gingival index	This measurement is based on the presence or absence of bleeding on gentle probing	Baseline
Primary	Bleeding on probing	Bleeding, leading sign of inflammation inside the connective tissue, is a critical factor for pocket depth measurements, and with other variable factors prevents making reproducible measurements.	Baseline
Secondary	Periodontal pocket depth	a pathologically deepened gingival sulcus around a tooth at the gingival margin.	Baseline
Secondary	Clinical attachment level	CAL is calculated by subtracting the gingival margin level from the probing depth.	Baseline